SciELO - Scientific Electronic Library Online

 
vol.20 número62Potencialidades y desafíos de la educación para la salud en la pandemia Covid-19La auriculoterapia en el control de la ansiedad y el estrés índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Enfermería Global

versión On-line ISSN 1695-6141

Enferm. glob. vol.20 no.62 Murcia abr. 2021  Epub 18-Mayo-2021

https://dx.doi.org/10.6018/eglobal.423431 

Originals

Quality of life related to health in people with hypertension and diabetes mellitus

Dora Inés Parra1    , Luis Alberto López Romero2  , Lina María Vera Cala3 

1Nurse, MSc Nurse. Clinical and Community Nursing Doctoral student, Universidad de Valencia, Spain.

Nursing School professor at Universidad Industrial de Santander, Bucaramanga, Colombia.

2 Nurse, MSc epidemiologist. Fundación Cardiovascular de Colombia.

3MD, MSc, PhD. Professor at Department of Public Health, School of Medicine, Universidad Industrial de Santander, Bucaramanga, Colombia.

ABSTRACT:

Objective

To determine the sociodemographic and clinical factors associated with health-related Quality of Life (HRQoL) among people with hypertension and type 2 diabetes mellitus.

Methods

Analytical cross-sectional study in a sample of 184 users of a cardiovascular risk control program in Bucaramanga (Colombia). The EQ-5D-3L instrument was used to assess quality of life. A multiple linear regression model was carried out using the Visual Analog Scale as the outcome and the dimensions of the EQ-5D as possible predictors, adjusting for age, sex, intervention group (instrumental variable), and clinical variables such as the disease and its control.

Results

The median of age was 63 years, 73.3% women, 88.0% low socioeconomic level; Median Systolic Blood Pressure of 130 mmHg (116.0-145.0) and HbA1c 5.7% (5.4-6.2) in the general population, showing statistically significant differences between the pathology groups. The median of Visual Analog Scale was 80(Q1: 59-Q3: 95) points, with no statistically significant differences between the pathology groups. Manifesting pain/discomfort, problems with usual activities and lack of hypertension control decreased the perception of HRQoL, by 7.5, 18.1 and 7.3 points, respectively.

Conclusions:

The HRQoL in general was high. It was higher among people with type 2 diabetes mellitus. Factors related to the functionality and control of the disease were associated with a lower perception HRQoL.

Key words: Health Related Quality of Life; HRQoL; Hypertension; Diabetes mellitus

INTRODUCTION

Life quality is a widely studied, complex and multifactorial concept encompassing each individual’s internal and external aspects 1,2. Great interest has surged in recent years in evaluating Health-Related Quality of Life (HRQoL) of healthy individuals and those affected with specific pathologies 3)(4)(5, due to the great usefulness of this indicator in resource allocation and evaluation of health policies.

On the other hand, chronic illnesses like hypertension and type 2 diabetes mellitus (DM2) are on the rise due to population ageing, making it more common to find people with more than one of these pathologies 6,7, which greatly affect their quality of life.

These conditions have traditionally been evaluated in terms of morbimortality 8, but as of recent years, great concern has risen among researchers and decision-makers in the estimation of the HRQoL of the people suffering these pathologies, given that they are affected not only by the presence of the disease, but also by the prescribed treatment and the life-style changes they must assume 9.

Hypertension can diminish the patients quality of life due to the multiple complications affecting the target organ and the side effects of antihypertensive medications, for which it is important to control hypertension, so as to significantly reduce risk of complications, and at the same time improve these patients’ quality of life 9. On the other hand, DM2 affects patients’ quality of life 6, due to its great financial and social burden 10,11) that not only impacts their health and well-being, but also their habits and lifestyles 12.

There are some factors related to the increase or decrease in the perception of HRQoL in patients with HT and DM2, such as sex, age, under control of the disease, type of disease, low educational level, dependence on caregivers, non-adherence to treatment, and mobility alterations, among others 13)(14)(15.

The previous context makes it necessary to evaluate the HRQoL of those affected by hypertension and DM2, and the factors that can affect it, in order to intervene potentially modifiable aspects improve their health status. In this regard, instruments exist that allow generic measurement of HRQoL, one of them being EQ-5D-3L, which determines the patient’s self-perception of health thru five dimensions: mobility, self-care, usual activities, pain/discomfort, anxiety/depression 16,17.

EQ-5D-3L is a tool ‘’applicable to an ample range of health ailments and treatments and it provides a simple descriptive profile and a unique index value usable for clinical and financial assessment of medical attention, and also in population health surveys” 16,17.

The objective of this study was to determine the sociodemographic and clinical factors associated with HRQoL in hypertensive and DM2 patients enrolled in a primary care program, who participated in a randomized clinical trial (RCT).

MATERIALS AND METHODS

Design and population

Analytical, cross-sectional study in a sample of 184 people participating in a randomized clinical trial (RCT) aiming to establish the efficacy of an educational intervention in raising adherence to treatment. Participants had medical diagnosis of hypertension or DM2 and were part of a cardiovascular risk control program in a primary care center in Bucaramanga (Colombia) between May 2016 and September 2017 18.

Instrument and measurements

All data were obtained along the RCT. The following variables were analyzed in this study:

Health-related quality of life, HRQoL (dependent variable), defined as the descriptive, evaluative, and predictive assessment of an individual’s health states, was evaluated using the EQ-5D-3L questionnaire, a tool to evaluate people’s health condition.

The EQ-5D-3L questionnaire is a two-part generic instrument. The first part is based on a multi-attribute classification encompassing five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression, and each one of them has three levels of severity: without problems, some or moderate problems, and severe problems, scored respectively by 1, 2 or 3 points, where the higher the scoring, the higher the problems in the different dimensions of the questionnaire, and the worse the health-related quality of life 19. A single digit expresses the level selected for that specific dimension.

For instance, “11111” indicates “without problems” for the five dimensions, while “21121” indicates some or moderate problems in the mobility dimension, no problems in the self-care and usual activities dimension, some or moderate problems in the pain/discomfort dimension, and no problems in the anxiety/depression dimension. Consequently, a result of 21133 indicates some or moderate problems in the mobility dimension, no problems in the self-care and usual activities dimension, and severe problems in the pain/discomfort and anxiety/depression dimensions.

The combination of the severity levels with all the dimensions defines health state, which correspond to 243 possibilities that can be used as profiles 20,21. The health states for each of the 5 dimensions are converted into a weighted health state index, assigning the preference weights of EQ-5D obtained from the general population sample. These weights fluctuate between 1 (Total health) and 0 (Death) 22.

The second part is a visual analogue scale (VAS) ranging from cero (0) as worst health state to 100, as optimal health state, getting an HRQoL index. Participants had to mark the point on the vertical line that best reflected assessment of their current global health state. It shows the patient’s general health state, representing a more integral measure than the EQ-5D index 14.

Clinical variables of disease control (Independent variables): Systolic blood pressure (SBP) was obtained through casual measuring and glycosylated hemoglobin (HbA1c) through blood sample (18). Hypertension control was defined as having SBP of <140 mmHg 23. In the same way, diabetes control was defined as having HbA1c <7.0 % in independent patients and free of other major comorbidities 24,25. Other variables included in the study were the patient´s disease (Hypertension, DM2, or both) and the RCT group (Intervened or control as instrumental variable of adjustment in the final model).

Sociodemographic variables (Independent variables): such as age in years, sex and socioeconomic status.

Data collection procedure

In order to obtain the current health state of all participants the EQ-5D-3L questionnaire results were taken; the questionnaire was applied during the last RCT measuring, at the end of the 12th month. Additional variables of interest (sociodemographic, clinical and RCT group) were also taken from the original study.

Data analysis

Descriptive analysis of the sociodemographic and clinical variables and the HRQoL was conducted, stratified according to patient’s pathology. Continuous variables were described through medians and their corresponding first and third quartiles, since they did not show a normal distribution according to the Shapiro Wilk statistical tests and Sktest testing. Polytomous nominal variables were described as absolute and relative frequencies.

The descriptive analysis related to HRQoL, consisted, first, in finding the health status of the participants by dimensions and state of severity according to the EQ-5D. Then the values ​​of all dimensions were combined, generating the possible health states or profiles of the study population. Subsequently, the global health status was determined by calculating the VAS central tendency measures accompanied by their respective dispersion measures.

Finally, the index of preference values ​​in each state of health generated by the EQ-5D (EQ-5D index) was obtained, taking as reference the coefficients for the calculation of social values ​​described in Spain 3. In addition, the Quality Adjusted Life Years (QALY) were determined by multiplying the EQ-5D index by the current age of the patient at the time of the interview.

Additionally, a bivariate analysis was carried out taking into account the patient´s disease comparing the medians of VAS, EQ-index, QALY as well as EQ-5D dimensions, which were analyzed in two categories: as “without problems” and “with problems”. Kruskal-Wallis test was used for continuous variables and Ji square test for categorical variables, respectively.

Finally, a model of robust multiple linear regression was carried out using VAS as outcome and the dimensions of EQ-5D, as possible main predictors, adjusting by age, sex, socioeconomic level, intervention group (instrumental variable), clinical variables such as disease control (Hypertension control and glycosylated hemoglobin control) and the patient’s disease (only hypertension, only DM2, or both). A p value lower than 0.05 was considered significant. All statistical tests were conducted as two-sided. Data were analyzed using statistical program STATA, version 14.0.

Ethical Considerations

This study was approved by two Institutional Review Boards (IRB). Written consent to be included in the original study was given by the participants. Information confidentiality was guaranteed through use of numerical codes in the databases. Permission to use the EQ-5D-3L instrument was obtained. Finally, the study complied with national and international regulation to conduct research in human beings 26.

RESULTS

Characteristics of participants

Table 1 shows the sociodemographic and clinical characteristics. The sample for this study consisted of 184 participants, with hypertension cases as majority (n=144). Some of the most relevant aspects are: median age of 63 years; most participants women (73.3%) and the low socioeconomic level was predominant (88.0%). It was also observable that no statistically significant differences arose between participants in terms of patient´s disease for sociodemographic characteristics, with the exception of clinical variables for disease control, such as SBP and HbA1c.

Table 1:  Sociodemographic and clinical characteristics of study participants 

ⱡ Ji square test for categorical variables and Kwallis test for continuous variables. This Table contains n (%) for categorical values, median (first and third quartile, Q1-Q3 for continuous variables). Abbreviations: SBP= Systolic Blood Pressure; HbA1c= glycosylated hemoglobin; HBP= High Blood Pressure.

Health State of Participants according to EQ-5D dimensions

Among the HRQoL dimensions, “self-care” was the least problematic at the general level (96.2%), and the most affected was “pain/ discomfort” (47.8%), without evidence of statistically significant association with the base disease. There was a statically significant association between the usual activities dimension, and the base pathology. Observation of the behavior of dimensions by pathology showed that DM2 patients had the highest percentage of no problems for three of the dimensions, except for pain/discomfort and anxiety/depression (Table 2).

Table 2:  Dimensions of health state of participants 

¥ Ji square test for categorical variables. HBP= High Blood Pressure

Health profiles of participants

Regarding the profiles, it is observable that five states are the most frequent in the study population, corresponding to 69.5% (n=128), of which 32.6% (n=60) of participants were in complete health state, corresponding to the values “11111”. In general, participants presented moderate problems, assigning a score of 2 to one or more of the five dimensions. Punctuation 3, corresponding to grave problems, was the most frequent for dimension 5 (anxiety/depression) of the EQ-5D-3L. No statistically significant differences were found between the groups by base pathologies.

Breaking up by base pathology determined that DM2 patients showed the highest proportion of this “complete health” state and a lower proportion of moderate or grave problems in some of the dimensions of the EQ-5D-3L, except for states 21111, 21122, 11122 and 11123, where frequency was higher, corresponding to moderate problems in the dimensions of mobility, pain/discomfort, anxiety/depression, and severe problems in the anxiety/depression dimension. Persons with hypertension were distributed in a greater number of states (Table 3).

Table 3:  Profiles of health state of participants 

ⱡ Ji square test; HBP= High Blood Pressure. Source: authors

Global health states of study participants and EQ-5D indices

The assessment of the global health status of all study participants by using the VAS was 80 (Q1: 59-Q3: 95) points and when disaggregating by underlying pathology, it was observed that people with DM2 obtained a higher score, without statistically significant differences between groups by pathology (Table 4).

Regarding the indices of preference values, it is observed that the EQ-5D Index was generally high for the study population, being higher in people with DM2 and lower in the population with HT / DM2 (Table 4). Regarding the QALYs, a higher value was found among the participants with DM2, but, again, without differences statistically significant between the disease groups.

Table 4:  EQ-5D indicators 

¥Kruskal-Wallis for continuous variables. Source: authors.

Factors associated with HRQoL in persons with hypertension and DM2

Model 2, adjusted by age, sex and intervention group, evidences that participants with pain/discomfort problems have on average 7.5 less points on the VAS as compared with those not affected by this problem.

Regarding model 3, adjusted by age, sex, intervened group, base pathology, controlled hypertension, and controlled DM2, it is observable that, on average, persons who have problems handling usual activities show 18.3 points less on the of VAS, as compared to those without such problems. Likewise, patients without hypertension control scored 7.1 points less on VAS than those who control it (Table 5).

Table 5:  Factors associated with HRQoL in persons with hypertension and DM2 

ⱡModel 1: β Raw; ¥Model 2: β adjusted by age, sex, socioeconomic level and group as instrumental variable; ¥¥Model 3: β adjusted by age, sex, socioeconomic level, group as instrumental variable, disease suffered, hypertension control, DM2 control. SE= Standard Error; *Systolic Pressure measured casually by <140mmHg; **HbA1c % <7.0 Source: authors

DISCUSSION

Main findings

People with chronic diseases such as hypertension and DM2 face long treatment processes and complications during the course of the disease, so their HRQoL may be affected. In this sense, it is important to measure people's perception of their HRQoL, since this allows us not only to know the preferences 2,3 of individuals for a series of health states but also to make clinical decisions based on the generation of indicators 27. Thus, it is important to have this type of information to design and implement effective actions to improve the HRQL of this population.

In this study it was found that in general the participants have a high perception of their health status, which was evidenced not only by the scores obtained in each of the EQ-5D indicators but also in a higher frequency of full health state. Likewise, statistically significant differences were found for the dimension of daily activities among the participants according to the disease they suffer. Finally, in the multivariate analysis, three factors were found that decrease the perception scores of HRQoL measured through VAS: pain / discomfort problems, problems with daily activities, and not controlling hypertension.

Comparison with other studies

In relation to the health states or health profiles, one study (28) found 169 states among a population of hypertensive individuals through a national survey in China, of which the most frequent was “complete health” (11111) with a value of 68.06%, and pain/discomfort was also highly frequent, a finding similar to those of our study 28.

As to the dimensions of health state, Viegas et al. in 2013 27 found that most participants did not have any personal care problems (97%), similar to our finding. With respect to presence of problems in these dimensions, pain/discomfort was the most frequent, with prevalence ranging between 61% and 38%, especially among individuals with DM2 and hypertension 14,27. Additionally, 30% prevalence has been reported for depression/anxiety problems; similar to the Figures we found 27.

Contrarily to the findings of our study, lower values have been found for problems in mobility (15.07%), pain/discomfort (25.96%), and anxiety (10.28%) in hypertensive population, as compared to population without a diagnosis for this pathology, differences that were statistically significant 28.

In relation to our findings about VAS, authors like Lu et al. in 2017 (13) and Bao et al., in 2019 (29), found values oscillating between 80.06 and 76.00 (±13.66) respectively, in persons with DM2 and hypertension, the same as the values of our study for the first case, but lower for the second.

As to the EQ-5D-3L index, Figures between 0.77 (0.75-0.79) and 0.95 (±0.14) in populations with DM2, hypertension or both pathologies, have been reported 14,27, results in most cases higher than those found in our study.

In terms of related factors that diminish the individual’s perception of their HRQoL, some studies have found aspects that agree with our findings, such as the presence of pain/discomfort 14,30), while others are the opposite, like association between the perception of HRQoL versus multi-morbidity and chronic ailments, where a strong correlation stands between hypertension and DM2 (OR adjusted=3.82), and hypertension 29) .Additionally, other aspects have been associated with individual HRQoL, especially in hypertension, like age, sex 28,31,32, and educational interventions 33, which are findings not evidenced in our study.

Although VAS is an evaluation tool with ample use, it is important to keep in mind that it is a subjective measure of quality of life and many other aspects.

Strengths and limitations of the study

The main strength of this study was its providing knowledge of HRQoL in population with DM2 and hypertension in our region through application of a generic instrument amply used worldwide, which allows us to have an approximation to the reality lived by patients in our primary attention context. Another strength is that the sample came from a RCT that used probabilistic sampling for selecting participants, guaranteeing population representation and makes the existence of selection bias unlikely.

The main limitation of the study was the size of the sample, which may have led to lack of sufficient power to find association between some characteristics of patients and their HRQoL. The other aspect was the absence of measure of other comorbidities that may have influenced the participants’ perception of their HRQoL.

CONCLUSIONS

The HRQoL of persons with DM2 and hypertension was high, according to the objective and subjective evaluation. There is no evidence of the existence of differences between the dimensions of HRQoL by underlying pathology, with the exception of the usual activities dimension. On the other hand, factors exist that can decrease the patient’s perception of HRQoL, such as problems related to usual activities, pain/discomfort problems, and non-control of hypertension.

Funding

The data used in this study were taken from the randomized controlled clinical trial “Teaching: Individual to Increase Adherence to Therapeutic Regimen in Hypertension Arterial and / or Diabetes Type 2 (ENURSIN)”, which was funded by COLCIENCIAS CT: 696-2014, code: 617399847755 and the Universidad Industrial de Santander, Colombia code 617399847755.

REFERENCES

1. Miniszewska J, Chodkiewicz J, Zalewska-Janowska A. [Quality of life in health and disease--what is it, how and why evaluate it]. Przegl Lek. 2012;69(6):253-9. [ Links ]

2. Palomino Moral PÁ, Frías Osuna A, del Pino Casado R, Moreno Cámara S. Capítulo 12 - Bienestar: la medición de la calidad de vida relacionada con la salud. En: Martínez Riera JR, del Pino Casado R, editores. Manual Práctico de Enfermería Comunitaria [Internet]. Madrid: Elsevier España; 2014 [citado 28 de octubre de 2020]. p. 59-66. Disponible en: http://www.sciencedirect.com/science/article/pii/B9788490224335000121 [ Links ]

3. Herdman M, Badia X, Berra S. El EuroQol-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria. Aten Primaria. 15 de octubre de 2001;28(6):425-30. [ Links ]

4. Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. octubre de 2019;28(10):2641-50. [ Links ]

5. Salter KL, Moses MB, Foley NC, Teasell RW. Health-related quality of life after stroke: what are we measuring? Int J Rehabil Res Int Z Rehabil Rev Int Rech Readaptation. junio de 2008;31(2):111-7. [ Links ]

6. Khan N, Rahman M, Mitra D, Afsana K. Prevalence of multimorbidity among Bangladeshi adult population: a nationwide cross-sectional study. BMJ Open. 28 de 2019;9(11):e030886. [ Links ]

7. Majumdar UB, Hunt C, Doupe P, Baum AJ, Heller DJ, Levine EL, et al. Multiple chronic conditions at a major urban health system: a retrospective cross-sectional analysis of frequencies, costs and comorbidity patterns. BMJ Open. 15 de 2019;9(10):e029340. [ Links ]

8. Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S, Campos-Nonato I, et al. Hipertensión arterial en adultos mexicanos: prevalencia, diagnóstico y tipo de tratamiento. Ensanut MC 2016. Salud Pública México. junio de 2018;60(3):233-43. [ Links ]

9. Guarín-Loaiza GM, Pinilla-Roa AE. Adherencia al tratamiento antihipertensivo y su relación con la calidad de vida en pacientes de dos hospitales de Bogotá, D.C. 2013-2014. Rev Fac Med. 1 de octubre de 2016;64(4):651-7. [ Links ]

10. Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, et al. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030. Diabetes Care. 2018;41(5):963-70. [ Links ]

11. Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423-30. [ Links ]

12. Fonseca S, Salvador R, Méndez C, Rafael P, Rodríguez V, Pérez P, et al. Calidad de vida en pacientes adultos mayores con Diabetes Mellitus tipo II. 2018;7. [ Links ]

13. Lu Y, Wang N, Chen Y, Nie X, Li Q, Han B, et al. Health-related quality of life in type-2 diabetes patients: a cross-sectional study in East China. BMC Endocr Disord [Internet]. 6 de julio de 2017 [citado 3 de noviembre de 2020];17. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501343/Links ]

14. Arifin B, Idrus LR, van Asselt ADI, Purba FD, Perwitasari DA, Thobari JA, et al. Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. mayo de 2019;28(5):1179-90. [ Links ]

15. Asakura R, Miyatake N, Mochimasu KD, Kurato R, Kuwana S. Comparison of health-related quality of life between type 2 diabetic patients with and without locomotive syndrome. Environ Health Prev Med. septiembre de 2016;21(5):356-60. [ Links ]

16. Reyes MXR, Gomez-Restrepo C, Rodríguez VA, Dennis-Verano R, Kind P. Calidad de vida relacionada con salud en la población Colombiana: ¿cómo valoran los colombianos su estado de salud? Rev Salud Pública. 1 de mayo de 2017;19(3):340-6. [ Links ]

17. Guías de usuario de EQ-5D - EQ-5D [Internet]. [citado 3 de noviembre de 2020]. Disponible en: https://euroqol.org/publications/user-guides/Links ]

18. Romero Guevara SL, Parra DI, Rojas LZ. "Teaching: Individual" to increase adherence to therapeutic regimen in people with hypertension and type-2 diabetes: protocol of the controlled clinical trial ENURSIN. BMC Nurs. 4 de junio de 2019;18(1):22. [ Links ]

19. Valuation of EQ-5D - EQ-5D [Internet]. [citado 28 de octubre de 2020]. Disponible en: https://euroqol.org/eq-5d-instruments/valuation-of-eq-5d/Links ]

20. Alfonso-Rosa RM, Pozo-Cruz JT del, Daza MC, Pozo-Cruz J del, Pozo-Cruz B del. Asociación entre la condición física relacionada con la salud y la calidad de vida en pacientes diabéticos tipo 2 tratados en atención primaria: un estudio exploratorio en la provincia de Sevilla. Rev Andal Med Deporte. 2012;5(3):91-8. [ Links ]

21. Golicki D, Dudzinska M, Zwolak A, Tarach JS. Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire. Adv Clin Exp Med Off Organ Wroclaw Med Univ. febrero de 2015;24(1):139-46. [ Links ]

22. Grandy S, Fox KM, SHIELD Study Group. Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study. Health Qual Life Outcomes. 21 de agosto de 2012;10:99. [ Links ]

23. European Society of Cardiology. Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial. Rev Esp Cardiol. 1 de febrero de 2019;72(2):160.e1-160.e78. [ Links ]

24. European Heart Journal. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD European Heart Journal Oxford Academic [Internet]. [citado 28 de octubre de 2020]. Disponible en: https://academic.oup.com/eurheartj/article/41/2/255/5556890Links ]

25. Ministerio de Salud y Protección Social. Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años. [Internet]. Ministerio de Salud y Protección Social; 2015. Disponible en: http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Conv_637/GPC_diabetes/Guia_Diabetes_Profesionales_Tipo_2.pdfLinks ]

26. Ministerio de Salud, Colombia. Resolución 008430, por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud [Internet]. Disponible en: https://www.unisabana.edu.co/fileadmin/Documentos/Investigacion/comite_de_etica/ Res__8430_1993_-_Salud.pdf Consultado: enero 04, 2018. [ Links ]

27. Andrade MV, Noronha KVM de S, Maia AC, Kind P. What matters most?: evidence-based findings of health dimensions affecting the societal preferences for EQ-5D health states. Cad Saúde Pública [Internet]. 2013 [citado 30 de enero de 2020];29:s59-72. Disponible en: http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0102-311X2013001300006&lng=en&nrm=iso&tlng=enLinks ]

28. Yao Q, Liu C, Zhang Y, Xu L. Health-Related Quality of Life of People with Self-Reported Hypertension: A National Cross-Sectional Survey in China. Int J Environ Res Public Health [Internet]. mayo de 2019 [citado 16 de marzo de 2020];16(10). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572246/Links ]

29. Bao X-Y, Xie Y-X, Zhang X-X, Peng X, Huang J-X, Du Q-F, et al. The association between multimorbidity and health-related quality of life: a cross-sectional survey among community middle-aged and elderly residents in southern China. Health Qual Life Outcomes. 24 de junio de 2019;17(1):107. [ Links ]

30. Liang Z, Zhang T, Lin T, Liu L, Wang B, Fu AZ, et al. Health-related quality of life among rural men and women with hypertension: assessment by the EQ-5D-5L in Jiangsu, China. Qual Life Res. 1 de agosto de 2019;28(8):2069-80. [ Links ]

31. Kamradt M, Krisam J, Kiel M, Qreini M, Besier W, Szecsenyi J, et al. Health-Related Quality of Life in Primary Care: Which Aspects Matter in Multimorbid Patients with Type 2 Diabetes Mellitus in a Community Setting? PloS One. 2017;12(1):e0170883. [ Links ]

32. Amer M, Ur-Rahman N, Nazir S-U-R, Jabeen M, Ehsan-Ul-Haq M. sessment Of Blood Pressure and Health-Related Quality of Life Among Hypertensive Patients: An Observational Study. Altern Ther Health Med. mayo de 2019;25(3):26-31. [ Links ]

33. Amer M, Rahman N, Nazir SR, Raza A, Riaz H, Sultana M, et al. Impact of pharmacist's intervention on disease related knowledge, medication adherence, HRQoL and control of blood pressure among hypertensive patients. Pak J Pharm Sci. noviembre de 2018;31(6 (Supplementary):2607-16. [ Links ]

FundingThe data used in this study were taken from the randomized controlled clinical trial “Teaching: Individual to Increase Adherence to Therapeutic Regimen in Hypertension Arterial and / or Diabetes Type 2 (ENURSIN)”, which was funded by COLCIENCIAS CT: 696-2014, code: 617399847755 and the Universidad Industrial de Santander, Colombia code 617399847755

Acknowledgements

To the Governor’s Office of Santander, Colombia, for the academic scholarship awarded to the main author of this study, granted through Colciencias convening 771 of 2016.

Received: April 18, 2020; Accepted: September 04, 2020

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons